Loomis Sayles & Co. L P Sells 2,378 Shares of Phreesia, Inc. (NYSE:PHR)

Loomis Sayles & Co. L P trimmed its position in Phreesia, Inc. (NYSE:PHR) by 0.3% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 808,371 shares of the company’s stock after selling 2,378 shares during the period. Loomis Sayles & Co. L P’s holdings in Phreesia were worth $42,117,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in PHR. Sageworth Trust Co bought a new position in Phreesia in the 1st quarter valued at $54,000. Altshuler Shaham Ltd boosted its position in shares of Phreesia by 134.4% in the 1st quarter. Altshuler Shaham Ltd now owns 1,739 shares of the company’s stock worth $91,000 after purchasing an additional 997 shares during the last quarter. Paloma Partners Management Co bought a new position in shares of Phreesia in the 4th quarter worth $231,000. Probity Advisors Inc. bought a new position in shares of Phreesia in the 1st quarter worth $240,000. Finally, Caxton Associates LP bought a new position in shares of Phreesia in the 1st quarter worth $243,000. Hedge funds and other institutional investors own 82.53% of the company’s stock.

In other news, Director Michael Weintraub sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, July 16th. The stock was sold at an average price of $63.76, for a total transaction of $1,275,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gillian Munson sold 3,055 shares of the business’s stock in a transaction that occurred on Thursday, July 8th. The stock was sold at an average price of $63.19, for a total value of $193,045.45. The disclosure for this sale can be found here. Insiders have sold 116,221 shares of company stock valued at $6,954,449 in the last quarter. 5.60% of the stock is currently owned by corporate insiders.

Several research analysts have recently issued reports on the company. KeyCorp raised their price target on Phreesia from $70.00 to $73.00 and gave the stock an “overweight” rating in a research report on Monday, July 12th. SVB Leerink reissued a “buy” rating on shares of Phreesia in a research note on Sunday, June 6th. JMP Securities began coverage on Phreesia in a research note on Tuesday, July 13th. They issued an “outperform” rating and a $80.00 price target on the stock. Robert W. Baird lifted their price target on Phreesia from $60.00 to $62.00 and gave the company an “outperform” rating in a research note on Monday, June 7th. Finally, Piper Sandler lifted their price target on Phreesia from $58.00 to $63.50 and gave the company an “overweight” rating in a research note on Monday, June 7th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Phreesia has a consensus rating of “Buy” and an average target price of $63.32.

Phreesia stock opened at $65.58 on Thursday. Phreesia, Inc. has a 52 week low of $26.50 and a 52 week high of $81.59. The company has a debt-to-equity ratio of 0.01, a current ratio of 10.01 and a quick ratio of 10.01. The stock’s 50-day simple moving average is $56.37.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, June 7th. The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.06). Phreesia had a negative return on equity of 11.34% and a negative net margin of 19.66%. The business had revenue of $48.30 million for the quarter, compared to the consensus estimate of $42.82 million. During the same quarter in the previous year, the business posted ($0.16) EPS. The company’s revenue for the quarter was up 44.6% on a year-over-year basis. As a group, sell-side analysts predict that Phreesia, Inc. will post -0.91 EPS for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.

Further Reading: What is the 52-week high/low?

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR).

Institutional Ownership by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.